Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-10

FDA Approved: ZIDOVUDINE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Zidovudine from Camber Pharmaceuticals, Inc., updating/expanding its approved use or labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zidovudine (Zidovudine)

Snippet

SUPPL AP for ZIDOVUDINE (ZIDOVUDINE)